87 related articles for article (PubMed ID: 34532463)
1. Genomic instability-associated lncRNA signature predicts prognosis and distinct immune landscape in gastric cancer.
Sun J; Jiang Q; Chen H; Zhang Q; Zhao J; Li H; Wang X; Fang Y; Ruan Y; Sun Y
Ann Transl Med; 2021 Aug; 9(16):1326. PubMed ID: 34532463
[TBL] [Abstract][Full Text] [Related]
2. Construction and validation of somatic mutation-derived long non-coding RNAs signatures of genomic instability to predict prognosis of hepatocellular carcinoma.
Duan BT; Zhao XK; Cui YY; Liu DZ; Wang L; Zhou L; Zhang XY
World J Gastrointest Surg; 2024 Mar; 16(3):842-859. PubMed ID: 38577085
[TBL] [Abstract][Full Text] [Related]
3. Long non-coding RNA signature for predicting gastric cancer survival based on genomic instability.
Zhang J; Chen L; Wei W; Mao F
Aging (Albany NY); 2023 Dec; 15(24):15114-15133. PubMed ID: 38127056
[TBL] [Abstract][Full Text] [Related]
4. Exploring Novel Genome Instability-associated lncRNAs and their Potential Function in Pan-Renal Cell Carcinoma.
Zhu HX; Zheng WC; Chen H; Chen JY; Lin F; Chen SH; Xue XY; Zheng QS; Liang M; Xu N; Chen DN; Sun XL
Comb Chem High Throughput Screen; 2023 Nov; ():. PubMed ID: 37957851
[TBL] [Abstract][Full Text] [Related]
5. The global landscape of immune-derived lncRNA signature in colorectal cancer.
Zhang M; Wu Y; Mou J; Yao Y; Wen P; Liu X; Shang S; Kang X; Tian J; Liu Y; Lv E; Wang L
Heliyon; 2024 Feb; 10(4):e25568. PubMed ID: 38420407
[TBL] [Abstract][Full Text] [Related]
6. The lncRNA Signatures of Genome Instability to Predict Survival in Patients with Renal Cancer.
Huang L; Xie Y; Jiang S; Han W; Zeng F; Li D
J Healthc Eng; 2021; 2021():1090698. PubMed ID: 34917302
[TBL] [Abstract][Full Text] [Related]
7. Taking aim at the genomic diversity of gastrointestinal cancers: a changing landscape.
Bekaii-Saab T; El-Rayes B
J Gastrointest Oncol; 2016 Oct; 7(5):673-674. PubMed ID: 27747081
[No Abstract] [Full Text] [Related]
8. Integrated Analysis of Stemness-Related LncRNAs Helps Predict the Immunotherapy Responsiveness of Gastric Cancer Patients.
Jiang Q; Chen L; Chen H; Tang Z; Liu F; Sun Y
Front Cell Dev Biol; 2021; 9():739509. PubMed ID: 34589496
[TBL] [Abstract][Full Text] [Related]
9. Stemness-related LncRNA pair signature for predicting therapy response in gastric cancer.
Jiang Q; Chen H; Tang Z; Sun J; Ruan Y; Liu F; Sun Y
BMC Cancer; 2021 Sep; 21(1):1067. PubMed ID: 34587919
[TBL] [Abstract][Full Text] [Related]
10. Identification of a Ferroptosis-Related Signature Model Including mRNAs and lncRNAs for Predicting Prognosis and Immune Activity in Hepatocellular Carcinoma.
Chen ZA; Tian H; Yao DM; Zhang Y; Feng ZJ; Yang CJ
Front Oncol; 2021; 11():738477. PubMed ID: 34568075
[TBL] [Abstract][Full Text] [Related]
11. Identification and validation of a novel immune-related signature associated with macrophages and CD8 T cell infiltration predicting overall survival for hepatocellular carcinoma.
Huo J; Wu L; Zang Y
BMC Med Genomics; 2021 Sep; 14(1):232. PubMed ID: 34544391
[TBL] [Abstract][Full Text] [Related]
12. Development and Validation of an Mesenchymal-Related Long Non-Coding RNA Prognostic Model in Glioma.
Huang K; Yue X; Zheng Y; Zhang Z; Cheng M; Li L; Chen Z; Yang Z; Bian E; Zhao B
Front Oncol; 2021; 11():726745. PubMed ID: 34540695
[TBL] [Abstract][Full Text] [Related]
13. Identification of a novel immune-related prognostic signature associated with tumor microenvironment for breast cancer.
Ding S; Sun X; Zhu L; Li Y; Chen W; Shen K
Int Immunopharmacol; 2021 Nov; 100():108122. PubMed ID: 34536743
[TBL] [Abstract][Full Text] [Related]
14. Wnt pathway-related three-mRNA clinical outcome signature in bladder urothelial carcinoma: computational biology and experimental analyses.
Sun S; Wang Y; Wang J; Bi J
J Transl Med; 2021 Sep; 19(1):409. PubMed ID: 34579753
[TBL] [Abstract][Full Text] [Related]
15. Identification of seven novel ferroptosis-related long non-coding RNA signatures as a diagnostic biomarker for acute myeloid leukemia.
Zheng Z; Wu W; Lin Z; Liu S; Chen Q; Jiang X; Xue Y; Lin D
BMC Med Genomics; 2021 Sep; 14(1):236. PubMed ID: 34579730
[TBL] [Abstract][Full Text] [Related]
16. A Four-Gene-Based Risk Score With High Prognostic Value in Gastric Cancer.
Zhang B; Li Y; Yang L; Chen Y
Front Oncol; 2021; 11():584213. PubMed ID: 34540650
[TBL] [Abstract][Full Text] [Related]
17. Construction of a Ferroptosis-Related Nine-lncRNA Signature for Predicting Prognosis and Immune Response in Hepatocellular Carcinoma.
Xu Z; Peng B; Liang Q; Chen X; Cai Y; Zeng S; Gao K; Wang X; Yi Q; Gong Z; Yan Y
Front Immunol; 2021; 12():719175. PubMed ID: 34603293
[TBL] [Abstract][Full Text] [Related]
18. ASF1B Promotes Oncogenesis in Lung Adenocarcinoma and Other Cancer Types.
Zhang W; Gao Z; Guan M; Liu N; Meng F; Wang G
Front Oncol; 2021; 11():731547. PubMed ID: 34568067
[TBL] [Abstract][Full Text] [Related]
19. Identification of Iron Metabolism-Related Genes as Prognostic Indicators for Lower-Grade Glioma.
Xu S; Wang Z; Ye J; Mei S; Zhang J
Front Oncol; 2021; 11():729103. PubMed ID: 34568059
[TBL] [Abstract][Full Text] [Related]
20. Comprehensive analyses of glycolysis-related lncRNAs for ovarian cancer patients.
Zheng J; Guo J; Zhu L; Zhou Y; Tong J
J Ovarian Res; 2021 Sep; 14(1):124. PubMed ID: 34560889
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
